Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform
RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine
Investment will help fund pre-market approval for use in spine, trauma and orthopaedics
Biocomposites, CEO, Michael Harris will join Renovos Biologics Board of Directors
